MedPath

Does Posterior Reconstruction of the Rhabdosphincter Improve Early Recovery of Continence After Robotic-Assisted Radical Prostatectomy?

Phase 3
Conditions
Urinary Incontinence
Registration Number
NCT01809522
Lead Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Brief Summary

The present study is a multicenter randomized, controlled trial, whose aim is to verify the effect of the posterior reconstruction of the rhabdosphincter after robot-assisted radical prostatectomy on early recovery of urinary continence.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
1500
Inclusion Criteria
  • Age ≥18 and ≤ 80 years;
  • Biopsy proven clinically localized prostate cancer;
  • Informed consent obtained and signed;
  • Understanding of, and willingness to comply with, the study procedures.
Exclusion Criteria
  • Pre-operative incontinence;
  • Salvage prostatectomy (defined as a prostatectomy prescribed after the failure of a different primary treatment);
  • Surgical posterior plane at the peri - rectal fat, without preserving an edge of the Denonvilliers;
  • History of psychiatric or addictive disorder or other medical condition that, in the opinion of the investigator, would preclude the patient from meeting the trial requirements;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Urinary continence12 months

No urinary leakages, assessed with the EPIC Questionnaire.

Secondary Outcome Measures
NameTimeMethod
Sexual potency12 months

Potency sufficient for intercourse, with or without use of PDE5i, assessed with the IIEF Questionnaire.

Oncologic radicality12 months

PSA \< 0,2 ng/ml.

Trial Locations

Locations (1)

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico

🇮🇹

Milano, Italy

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
🇮🇹Milano, Italy
Bernardo Rocco, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.